0001127602-21-010812.txt : 20210316
0001127602-21-010812.hdr.sgml : 20210316
20210316163759
ACCESSION NUMBER: 0001127602-21-010812
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20210316
DATE AS OF CHANGE: 20210316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EDGEMOND JAMES
CENTRAL INDEX KEY: 0001636178
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 21746353
MAIL ADDRESS:
STREET 1: 1040 SPRING STREET
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-03-15
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001636178
EDGEMOND JAMES
1040 SPRING STREET
SILVER SPRING
MD
20910
1
CFO and Treasurer
Common Stock
1229
D
Stock Options
111.00
2018-03-15
4
A
0
75349
0
A
2021-03-15
2018-03-15
Common Stock
75349
75349
D
Includes 156 shares acquired on March 4, 2021 under the United Therapeutics Corporation Employee Stock Purchase Plan.
These performance-based stock options were initially awarded on March 15, 2018, subject to a three-year performance condition tied to average cash profit margin during 2018-2020, which was determined on February 24, 2021. Number of stock options reported represents the number of options earned based on performance.
/s/ John S. Hess, Jr. under Power of Attorney
2021-03-16